All blog items

Glioblastoma brain tumors can have an unusual effect on the body’s immune system, often causing a dramatic drop in the number of circulating T-cells that help drive the body’s defenses.    Where the T-cells go has been unclear, even as immunotherapies are increasingly employed to stimulate the body’s natural ability to fight invasive tumors.  

Thursday, September 27, 5:00-7:00pm

Colin S. Duckett, PhD, chief scientific officer of the Baylor Scott & White Research Institute and professor in the Department of Medicine in the Baylor College of Medicine in Houston, Texas, has been named the new vice dean for basic science for the Duke University School of Medicine, it was announced today by Mary E. Klotman, MD, Dean, Duke University School of Medicine. Dr. Duckett will begin his service as vice dean on September 4, 2018. 

OnCore Community News iRIS Community News Research Community News DOCR News Did You Know? Training Opportunities Clinical Research Employee Highlights Partner Resources OnCore Community News  

Back row (from left): Scott Palmer, MD; David Harpole, MD; Andrew Alspaugh, MD; Dee Gunn, MD; Rasheed Gbadegesin, MD, MBBS; Gerry Blobe, MD, PhD. Front row (from left): Maria Price-Rapoza, PhD; Stephanie Freel, PhD; Sallie Permar, MD, PhD; Ashley Grantham, PhD; Jillian Hurst, PhD. Physician scientists—those who hold MD or MD/PhD degre

Eight of the ten deans at Duke are now women. Deans Klotman, Kelley, and McClain were interviewed by WRAL about being in the majority among deans at Duke.  Watch video at WRAL.com  

  In June, NIH switched to their new Human Subjects System (HSS) for reporting progress with clinical trials and human subjects studies. In recent weeks, some folks preparing their Research Performance Progress Reports, or RPPRs, struggled to find instructions of how to apply the new system to their research updates.

  As you may have seen, NIH released a notice last week regarding “FORMS-E” and related human subjects policies. I expect this notice, "Delayed Enforcement and Short-Term Flexibilities for Some Requirements Affecting Prospective Basic Science Studies Involving Human Participants", will be the first of many responses to Congressional concerns about the NIH application requirements for clinical trials (see the Consolidated Appropriations Act, 2018, Public Law 115-141).

OnCore Community News iRIS Community News Research Community News DOCR News Did You Know? Training Opportunities Clinical Research Employee Highlights Partner Resources OnCore Community News  

We need your feedback!